OVIT (OncoVista Innovative Therapies) Days Sales Outstanding: 0.00 (As of Sep. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoVista Innovative Therapies Days Sales Outstanding?

OncoVista Innovative Therapies OVIT Days Sales Outstanding is 0.00 as of Sep. 2015.

OncoVista Innovative Therapies's average Accounts Receivable for the three months ended in Sep. 2015 was $0.00 Mil. OncoVista Innovative Therapies's Revenue for the three months ended in Sep. 2015 was $0.00 Mil.

The historical rank and industry rank for OncoVista Innovative Therapies's Days Sales Outstanding or its related term are showing as below:

OVIT's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 69.33
* Ranked among companies with meaningful Days Sales Outstanding only.

OncoVista Innovative Therapies's Days Sales Outstanding stayed the same from Sep. 2014 (0.00) to Sep. 2015 (0.00).

OncoVista Innovative Therapies  (OTCPK:OVIT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

OncoVista Innovative Therapies Days Sales Outstanding Related Terms

OncoVista Innovative Therapies Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Days Sales Outstanding Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OVIT vs RSPI, HSTC, CAPS: Days Sales Outstanding Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies Days Sales Outstanding vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Days Sales Outstanding falls into.


OncoVista Innovative Therapies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

OncoVista Innovative Therapies's Days Sales Outstanding for the fiscal year that ended in Dec. 2014 is calculated as

Days Sales Outstanding (A: Dec. 2014 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2013 ) + Accounts Receivable (A: Dec. 2014 )) / count ) / Revenue (A: Dec. 2014 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

OncoVista Innovative Therapies's Days Sales Outstanding for the quarter that ended in Sep. 2015 is calculated as:

Days Sales Outstanding (Q: Sep. 2015 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2015 ) + Accounts Receivable (A: Sep. 2015 )) / count ) / Revenue (A: Sep. 2015 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 0.00 mean?
OncoVista Innovative Therapies (OVIT) has a Days Sales Outstanding of 0.00 as of Sep. 2015. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Days Sales Outstanding too high?
OncoVista Innovative Therapies' current Days Sales Outstanding is 0.00.
How does OncoVista Innovative Therapies' Days Sales Outstanding compare to RSPI and HSTC?
OncoVista Innovative Therapies' Days Sales Outstanding of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Sales Outstanding is 69.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 69.33, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on OncoVista Innovative Therapies and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 69.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OncoVista Innovative Therapies's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Days Sales Outstanding is 0.00 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.